|
Nov 25, 2024
|
Zimmer Biomet Receives FDA Approval for Oxford® Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S.
|
|
|
Nov 21, 2024
|
Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference
|
|
|
Nov 18, 2024
|
Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System
|
|
|
Nov 13, 2024
|
Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer
|
|
|
Nov 07, 2024
|
Zimmer Biomet to Present at Jefferies London Healthcare Conference
|
|
|
Oct 30, 2024
|
Zimmer Biomet Announces Third Quarter 2024 Financial Results
|
|
|
Oct 28, 2024
|
Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting
|
|
|
Oct 09, 2024
|
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results
|
|
|
Sep 05, 2024
|
Zimmer Biomet Names David DeMartino as Senior Vice President, Investor Relations
|
|
|
Aug 29, 2024
|
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024
|
|